Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
This Amendment No. 1 to Current Report on Form 8-K/A (the "Amendment") amends
the Current Report on Form 8-K of Inogen, Inc. (the "Company") dated March 22,
2022 and filed with the Commission on March 23, 2022 (the "Original Form 8-K"),
which disclosed the appointment of each of Kevin King, Mary Kay Ladone, and
Glenn Boehnlein to the Board of Directors of the Company (the "Board"),
effective March 22, 2022. At the time of filing of the Original Form 8-K, as
disclosed in the Original Form 8-K, the Board appointed Mr. King as a member of
the Audit Committee of the Board (the "Audit Committee") and chairperson of the
Compensation Committee of the Board (the "Compensation Committee"), Ms. Ladone
as a member of the Audit Committee and the Compensation Committee, and Mr.
Boehnlein as chairperson of the Audit Committee. At the time of filing the
Original Form 8-K, no determination had been made with respect to the
appointment of any such directors to the Compliance Committee of the Board (the
"Compliance Committee"). This Amendment is being filed solely to report that on
April 14, 2022, upon the recommendation of the Nominating and Governance
Committee of the Board, the Board appointed Mr. Boehnlein to the Compliance
Committee, effective immediately. Effective upon such appointment, the members
of the Compliance Committee are Elizabeth Mora (Chair), Kristen Miranda, and
Glenn Boehnlein.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses